Image Credit: zimmytws / Shutterstock A recent review published in The Nurse Practitioner highlights the expanding clinical role of glucagon-like peptide-1 receptor agonists (GLP-1RAs), which have also drawn widespread media attention for their rapid weight-loss effects
Most patients notice appetite reduction within days and measurable weight loss by week 2 to 3, with consistent 1 to 2 pounds weekly loss by month 2
The CDMO expanded a facility in West Chester, Ohio, in 2023
That ranking is not surprising, but it was measured here across 54 substances at once, and that is rare
Matza LS, Stewart KD, Land LF, Patel H, Boye KS (2022) Exit interviews examining the patient experience in clinical trials of tirzepatide for treatment of type 2 diabetes
Sachverstndiger